Cohen & Steers Acquires Significant Stake in CareTrust REIT; Analysts Project Modest Upside and Overvaluation Concerns

Cohen & Steers has acquired an 8.5 million share stake in CareTrust REIT, highlighting strategic interest in the REIT sector. Analysts project a modest 1.07% upside for CareTrust REIT, with an average target price of $34.13. GuruFocus metrics suggest potential overvaluation of the stock, with an estimated GF Value of $24.77 in one year, implying a 26.64% downside from current trading price.

Cohen & Steers has recently acquired an 8.5 million share stake in CareTrust REIT (CTRE), signaling a strategic interest in the REIT sector. The acquisition comes as analysts project a modest 1.07% upside for CareTrust REIT, with an average target price of $34.13. However, GuruFocus metrics suggest potential overvaluation, with an estimated GF Value of $24.77 in one year, implying a 26.64% downside from the current trading price [2].

CareTrust REIT, a self-managed REIT focused on healthcare properties, has been a notable performer in the sector. It owns 581 properties across 34 U.S. states and the UK, with a diversified operator base and a strong track record of acquisitions. In the past two years, CTRE has made significant acquisitions, including a landmark deal in the UK that added $69 million in annualized rent and 134 properties to its platform [1].

Despite the recent acquisition, CTRE continues to see solid growth, with normalized FFO per share growing by 19% YoY to $0.43 and normalized FAD growing by 16% YoY. This growth is driven by organic rent escalators and substantial acquisitions totaling $2.7 billion over the past 18 months [1]. The company's operator health is also robust, with an EBITDARM-to-Rent coverage of 2.72x portfolio-wide [1].

Analysts have a generally positive outlook on CTRE, with a consensus buy rating and a price target of $34.13, suggesting a modest upside of 1.07% [2]. However, GuruFocus metrics caution against potential overvaluation, with a GF Value of $24.77 in one year, indicating a 26.64% downside risk [2].

Investors should consider these projections and the potential risks, such as changes in Medicare reimbursement policies and the impact of equity issuances on growth, before making investment decisions.

References:
[1] https://www.marketwatch.com/investing/stock/ctre
[2] https://seekingalpha.com/article/4814819-caretrust-reit-firing-on-all-cylinders